TL;DR: Relevium Medical is a Y Combinator Summer 2022 startup Platform injectable gel based therapeutic for osteoarthritis, currently active with a team of 5.
Platform injectable gel based therapeutic for osteoarthritis
Last verified:
Relevium Medical is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease. Right now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease is progressive and only gets worse over time, many patients end up on highly addictive, high-dose opioids. To date, we have secured $3.7 million in non dilutive funding and completed preclinical testing. We demonstrated that our drug is safe, selectively blocks nerves that transmit pain, and provides pain relief that lasts four times as long. Insurance currently pays $770 per six-monthly treatment for knee osteoarthritis. With 5 million patients in the US, this represents a $…
Built by LemStudio
Yes. Relevium Medical was funded by Y Combinator in the Summer 2022 batch. Platform injectable gel based therapeutic for osteoarthritis
Relevium Medical is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease. Right now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease…
Relevium Medical was part of Y Combinator's Summer 2022 batch.
Relevium Medical has a team of 5 people according to Y Combinator's directory.
Relevium Medical is currently listed as Active with a team of 5 in Y Combinator's directory.
Loading interactive view…